Shanghai Junshi Biosciences Co., Ltd. (JUNSHI BIO) has scheduled a board meeting for 26 August 2026 in Shanghai to consider and approve the Group’s interim financial results for the six months ended 30 June 2026. The agenda will also include other corporate matters.

The board currently comprises seven executive directors—Xiong Jun (Chairman), Li Ning, Zou Jianjun, Li Cong, Zhang Zhuobing, Wang Gang and Li Xin—alongside two non-executive directors, Yao Sheng and Tang Yi, and five independent non-executive directors, Feng Xiaoyuan, Li Zhongxian, Lu Kun, Yang Jin and Chen Liang.

Further details, including financial figures for the first half of 2026, are expected to be released following board approval.